ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,307.01
      -0.27%
      US Tech 100
      18,307.16
      0.41%
      Dow Jones
      39,671.04
      -0.51%
      Brent Oil
      81.175
      -0.44%
      Bitcoin
      69,376.99
      0.40%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Idorsia Ltd (0RQE)

      7. Idorsia Ltd (0RQE) News

      0RQE Idorsia Ltd

      1.9775
      0.00 (0.00%)
      May 21 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Idorsia Ltd 0RQE London Ordinary Share
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 1.9775 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      1.9775 1.9775
      more quote information »

      Recent News

      Date Time Source Heading
      5/23/202401:00UKREGIdorsia issues invitation to the 2024 Annual General Meeting..
      5/23/202401:00UKREGIdorsia issues invitation to the 2024 Annual General Meeting..
      5/21/202401:00UKREGIdorsia announces changes to Idorsia Executive Committee and..
      5/21/202401:00UKREGIdorsia announces changes to Idorsia Executive Committee and..
      5/21/202400:50UKREGIdorsia announces financial results for the first quarter..
      5/21/202400:50UKREGIdorsia announces financial results for the first quarter..
      5/21/202400:40UKREGIdorsia announces financial results for the full year of..
      5/21/202400:40UKREGIdorsia announces financial results for the full year of..
      5/14/202411:45UKREGInvitation to Idorsia's Full Year 2023 and Q1 2024 Financial..
      5/14/202411:45UKREGInvitation to Idorsia's Full Year 2023 and Q1 2024 Financial..
      5/06/202412:35UKREGBondholders approve amended terms of the 2024 convertible..
      5/06/202412:35UKREGBondholders approve amended terms of the 2024 convertible..
      5/01/202412:00UKREGIdorsia increases the consent fee in connection with the..
      5/01/202412:00UKREGIdorsia increases the consent fee in connection with the..
      4/26/202401:00UKREGJERAYGO (aprocitentan) recommended for approval in Europe..
      4/26/202401:00UKREGJERAYGO (aprocitentan) recommended for approval in Europe..
      4/23/202401:00UKREGIdorsia publishes an invitation to a bondholder meeting
      4/23/202401:00UKREGIdorsia publishes an invitation to a bondholder meeting
      4/17/202401:00UKREGIdorsia publishes a Financial Status required for an..
      4/17/202401:00UKREGIdorsia publishes a Financial Status required for an..
      4/11/202401:00UKREGIdorsia takes steps to address short-term liquidity needs
      4/11/202401:00UKREGIdorsia takes steps to address short-term liquidity needs
      3/22/202402:00UKREGIdorsia thanks Guy Braunstein for his years of service as he..
      3/22/202402:00UKREGIdorsia thanks Guy Braunstein for his years of service as he..
      3/20/202402:00UKREGUS FDA approves Idorsia’s once-daily TRYVIO (aprocitentan) –..
      3/20/202402:00UKREGUS FDA approves Idorsia’s once-daily TRYVIO (aprocitentan) –..
      3/18/202402:00UKREGIdorsia and Viatris successfully close the transaction for..
      3/18/202402:00UKREGIdorsia and Viatris successfully close the transaction for..
      2/28/202401:00UKREGIdorsia and Viatris enter into a significant global research..
      2/28/202401:00UKREGIdorsia and Viatris enter into a significant global research..
      1/10/202401:00GLOBEIdorsia presents at the J.P. Morgan Healthcare Conference –..
      11/03/202317:30GLOBENew Phase 3 data with aprocitentan for patients with..
      10/24/202301:00GLOBEIdorsia announces financial results for the first nine..
      10/23/202301:00GLOBEIdorsia is committed to further the science of sleep with a..
      10/17/202311:45GLOBEInvitation to Idorsia's Nine-Month 2023 Financial Reporting..
      9/06/202301:00GLOBEIdorsia reacquires the world-wide rights to aprocitentan
      7/25/202301:00GLOBEIdorsia announces financial results for the first half 2023..
      7/21/202301:00GLOBEIdorsia announces a cost reduction initiative to be..
      7/20/202302:30GLOBEIdorsia sells its Asia Pacific (ex-China) operations –..
      7/18/202311:45GLOBEInvitation to Idorsia's HY 2023 Financial Results webcast..
      7/10/202301:00GLOBEIdorsia announces its insomnia medication, QUVIVIQ..
      6/26/202311:45GLOBENew Phase 3 data with aprocitentan for patients with..
      6/23/202311:45GLOBENew Phase 3 data with aprocitentan to be presented at the..
      6/20/202301:00GLOBEIdorsia has secured bridge financing in the amount of CHF..
      6/12/202301:00GLOBEIdorsia launches QUVIVIQ (daridorexant) in Switzerland – a..
      6/06/202301:00GLOBEIdorsia has entered into exclusive negotiations with regard..
      5/30/202301:00GLOBEIdorsia announces a change to commercial leadership

      Your Recent History

      LSE
      0RQE
      Idorsia
      Delayed Upgrade Clock